home

US Market news

headline news | recent news | latest news | market news | recent topics | stock topics

Global news - chevrons indicate local prediction, arrows show global predictions, circles show importance

AMRS US
The Differences Between AMRs and AGVs
AGVs have served warehouses faithfully for decades, but AMRs are bringing new changes to warehouse processes enabling manufacturers to better address consumer demand and industry labor shortages. - automationworld
13:00 Thu
link
ALB US
Why Albemarle Stock Is Surging This Week
Lithium prices are rebounding after plunging 80% in 2023. - fool
26m ago
link
SPR US
Fuselage maker Spirit Aerosystems surges on report that Boeing could buy it back
Shares of Spirit Aerosystems, the fuselage maker for Boeing's 737 Max jets, surged Friday after a report that Boeing is in talks to acquire the company. - cnbc
28m ago
link
MTZ US
Why MasTec Stock Is Gaining Ground Today
There are signs economic headwinds are slowly subsiding. - fool
36m ago
link
VOLC US
Millions awarded to White Island volcano victims
The 2019 New Zealand volcano eruption killed 22 people and gravely injured 25 others. - bbci co uk
39m ago
link
ADSK US
Autodesk's Outlook Has Several Moving Parts, But 7 Analysts Are Raising Forecasts
Shares of Autodesk Inc (NASDAQ: ADSK ) were climbing in early trading on Friday, after the company reported higher-than-expected results for the fourth quarter . The results came amid an exciting earnings season . Here are some key analyst takeaways from the release. Goldman Sachs analyst Kash Rangan maintained a Sell rating, while raising the price target from $180 to $230. RBC Capital Markets analyst Matthew Hedberg reiterated an Outperform rating, while lifting the price target from $290 to $320. Stifel analyst Adam Borg reaffirmed a Buy rating, while raising the price target from $265 to $316. BMO Capital Markets analyst Daniel Jester maintained a Market Perform rating, while lifting the price target from $232 to $293. KeyBanc analyst Jason Celino reiterated an Overweight rating, while raising the price target from $275 to $320. Mizuho Securities analyst Siti Panigrahi reaffirmed a Buy rating, while lifting the price target from $220 to $270. Piper Sandler a - benzinga
42m ago
link
REGN US
Decoding Regeneron Pharmaceuticals's Options Activity: What's the Big Picture?
Investors with a lot of money to spend have taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ: REGN ). And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with REGN, it often means somebody knows something is about to happen. Today, Benzinga's options scanner spotted 8 options trades for Regeneron Pharmaceuticals . This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 62%, bearish. Out of all of the options we uncovered, there was 1 put, for a total amount of $49,380, and 7, calls, for a total amount of $489,368. Expected Price Movements Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $620.0 to $980.0 for Regener - benzinga
42m ago
link
YHOO US
One year after buying a failed bank, New York Community Bancorp is struggling - Yahoo Finance
One year after buying a failed bank, New York Community Bancorp is struggling    Yahoo Finance Shares of NYCB fall more than 20% after bank discloses 'internal controls' issue, CEO change    CNBC NYCB's commercial real estate exposures among 'key concerns'    Yahoo Finance Stock Market Today: Dow, S&P 500 Edge Up; NYCB Stock Price Tumbles    The Wall Street Journal Shares of New York Community Bancorp plummet amid CEO exit and loan woes    CBS News - news google
51m ago
link
POETF US
Poet reveals four-year domestic abuse ordeal
'Scots word of the day' poet Len Pennie has hidden her struggle against a violent ex-partner. - bbci co uk
52m ago
link
FRPT US
Why Freshpet Stock Jumped This Week
Freshpet continued to outpace the industry. - fool
54m ago
link
DIS US
3 Dates for Disney Stock Investors to Circle in March
Disney stock is up 24% through the first two months of 2024. - fool
54m ago
link
ACM US
$1000 Invested In AECOM 5 Years Ago Would Be Worth This Much Today
AECOM (NYSE: ACM ) has outperformed the market over the past 5 years by 10.62% on an annualized basis producing an average annual return of 23.48%. Currently, AECOM has a market capitalization of $12.08 billion. Buying $1000 In ACM: If an ... Full story available on Benzinga.com - benzinga
59m ago
link
NTAP US
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. Shares of The Cooper Companies, Inc. (NYSE: COO ) rose sharply during Friday’s session after the company reported better-than-expected first-quarter financial results and raised guidance . Cooper Companies posted adjusted earnings of 85 cents per share, beating market estimates of 78 cents per share. The company’s quarterly sales came in at $931.60 million versus expectations of $915.94 million, according to data from Benzinga Pro . The Cooper Companies shares rose 7.4% to $100.61 on Friday. Here are some other big stocks recording gains in today’s session. Dell Technologies Inc. (NYSE: DELL ) jumped 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%. Sweetgreen, Inc. (NYSE: SG ) rose 26% to $16.05 after the company reported better-than-expected fourth-quarter financial r - benzinga
1h ago
link
EWW US
Europe facing uncontrollable surge of migrants as asylum applications hit 7 year high
More than one million migrant applications were lodged in 2023. - feedburner
1h ago
link
ZS US
Should Investors Worry About Zscaler's Deceleration? 12 Analysts Provide Takeaways
Shares of Zscaler Inc (NASDAQ: ZS ) tanked in premarket trading on Friday, after the company reported higher-than-expected sales and earnings for the fiscal second quarter . The results came amid an exciting earnings season . Here are some key analyst takeaways from the release. Goldman Sachs analyst Gabriela Borges maintained a Neural rating, while raising the price target from $189 to $215. Wedbush analyst Daniel Ives maintained an Outperform rating, while raising the price target from $250 to $260. RBC Capital Markets analyst Matthew Hedberg reiterated an Outperform rating, while lifting the price target from $260 to $265. Cantor Fitzgerald analyst Yi Fu Lee reaffirmed a Neutral rating, while reducing the price target from $250 to $230. BMO Capital Markets analyst Keith Bachman maintained an Outperform rating, while cutting the price target from $268 to $255. Piper Sandler analyst Rob Owens reiterated an Overweight rating and price target of $255. Stifel anal - benzinga
1h ago
link
TXT US
$1000 Invested In Textron 15 Years Ago Would Be Worth This Much Today
Textron (NYSE: TXT ) has outperformed the market over the past 15 years by 8.66% on an annualized basis producing an average annual return of 23.02%. Currently, Textron has a market capitalization of $17.18 billion. Buying $1000 In TXT: If an ... Full story available on Benzinga.com - benzinga
1h ago
link
PCRX US
Navigating 4 Analyst Ratings For Pacira BioSciences
Across the recent three months, 4 analysts have shared their insights on Pacira BioSciences (NASDAQ: PCRX ), expressing a variety of opinions spanning from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 1 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $47.25, along with a high estimate of $57.00 and a low estimate of $42.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 10.85%. Interpreting Analyst Ratings: A Closer Look An in-depth analysis of rec - benzinga
1h ago
link
AMRX US
Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday?
Friday,  Amneal Pharmaceuticals Inc  (NASDAQ: AMRX ) reported fourth-quarter 2023 revenues of $616.98 million, up 1% Y/Y, missing the  consensus of $634.23 million . The increase was driven by AvKARE revenues growing 38% due to new launches and Specialty revenues growing 2% driven by key branded products, partially offset by Generics revenues declining 9% as the strong performance of biosimilars and complex generics was  offset by the timing of orders .  Amneal Pharmaceuticals’ adjusted EPS decreased 39% to $0.14, beating the consensus of $0.09. Net ... Full story available on Benzinga.com - benzinga
1h ago
link
ADBE US
How Is The Market Feeling About Adobe?
Adobe's (NYSE: ADBE ) short percent of float has fallen 5.93% since its last report. The company recently reported that it has 4.99 million shares sold short , which is 1.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.09 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
1h ago
link
AAPL US
Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List
A leading financial analyst company has removed technology giant Apple Inc (NASDAQ: AAPL ) from its 'Conviction List' one month after first-quarter earnings were reported. What Happened: Apple has had several eventful months with the release of the iPhone 15 in September and the Vision Pro mixed reality headset in February. Goldman Sachs Group (NYSE: GS ) removed Apple from its Conviction List, but notes that the stock remains Buy rated. The price target for Apple was $232 in the latest note from Goldman Sachs after first-quarter earnings. 'There are many reasons a stock could get removed from the list. The can include (but are not limited to), analysts no longer having conviction in their idea, price realization, the passage of catalysts or the subcommittee believing there are better opportunities elsewhere,' the company said. Given that Apple retains a Buy rating, it suggests that the analysts’ belief in the stock hasn’t waned. With Apple’s shares - benzinga
1h ago
link
CMG US
Decoding Chipotle Mexican Grill's Options Activity: What's the Big Picture?
Investors with a lot of money to spend have taken a bearish stance on Chipotle Mexican Grill (NYSE: CMG ). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CMG, it often means somebody knows something is about to happen. So how do we know what these investors just did? Today, Benzinga 's options scanner spotted 8 uncommon options trades for Chipotle Mexican Grill. This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 62%, bearish. Out of all of the special options we uncovered, 5 are puts, for a total amount of $490,010, and 3 are calls, for a total amount of $426,350. Expected Price Movements Taking into account the Volume and Open Interest on these contracts, it appears that whales hav - benzinga
1h ago
link
NVO US
What the Options Market Tells Us About Novo Nordisk
Whales with a lot of money to spend have taken a noticeably bearish stance on Novo Nordisk . Looking at options history for Novo Nordisk (NYSE: NVO ) we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 69% with bearish. From the overall spotted trades, 3 are puts, for a total amount of $111,064 and 10, calls, for a total amount of $556,217. What's The Price Target? After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $95.0 and $145.0 for Novo Nordisk, spanning the last three months. Volume & Open Interest Trends Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Novo Nordisk's options at specified strike prices. The forthcoming data visualizes ... Full story available - benzinga
1h ago
link
UNH US
What's Going With UnitedHealth Stock On Friday?
Healthcare providers nationwide are grappling with financial challenges as a week-long ransomware outage at a  UnitedHealth Group Inc’s  (NYSE: UNH ) tech unit   disrupts payment processing .  The American Hospital Association (AHA) reports that small and large providers are facing cash shortages, with some forced to absorb upfront costs due to their inability to collect payments. According to a report on Tuesday, Hackers affiliated with the ‘Blackcat’ ransomware gang were responsible for the ongoing outage at UnitedHealth’s technology unit, causing significant disruptions to prescription deliveries for the past six days. Last week, the health insurance and services company identified a suspected nation-state-associated cyber security threat actor that had gained access to some of the ... Full story available on Benzinga.com - benzinga
2h ago
link
WBD US
FuboTV CEO slams pernicious rivals Disney, Fox and WBD amid streaming lawsuit
FuboTV shares soared in premarket trades, but are down 8.2% despite the streaming companys narrower-than-expected loss and better-than-expected revenue in its fourth-quarter results. - marketwatch
2h ago
link
BIVI US
Why Is Alzheimer's/Parkinson's Focused BioVie Stock Surging On Friday?
BioVie Inc (NASDAQ: BIVI ) shares are trading higher after the drug developer announced two upcoming presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024 . The Carson City, Nevada-based company’s stock is trading on a session volume of 8.96 million compared to an average volume of 536.8K, as per data from Benzinga Pro . Improvements in non-motor symptoms correlated with improvements in motor symptoms for Parkinson’s Disease patients. Data from phase 2a placebo-controlled study suggest improvements in NE3107-treated patients with non-motor symptoms.  NE3107-treated patients experienced a significant improvement of -2.4 points for the sleep/fatigue domain of the Non-Motor Symptom Scale (NMSS) in Parkinson’s Disease, whereas placebo patients experienced a worsening of +1.0 points (p=0.0159).  Sleep/fatigue domain improvements correlated with motor score improvements.  More ... Full story - benzinga
2h ago
link
TSM US
$35k in $TSM in anticipation of April Earnings being a huge beat
TLDR: 2024 is the year of the semis and TSM is where Im putting my money. $33k in shares and $2k in calls. Will continue to add to the calls over the next few weeks ahead of the April earnings. submitted by /u/ieatporkrindshehe [link] [comments] - reddit
2h ago
link
MDB US
Unpacking the Latest Options Trading Trends in MongoDB
Deep-pocketed investors have adopted a bullish approach towards MongoDB (NASDAQ: MDB ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MDB usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for MongoDB. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 6 are puts, totaling $301,484, and 8 are calls, amounting to $307,727. What's The Price Target? Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $420.0 to $480.0 for MongoDB over the recent three months. - benzinga
2h ago
link
ADM US
Archer-Daniels Midland's Options: A Look at What the Big Money is Thinking
Deep-pocketed investors have adopted a bearish approach towards Archer-Daniels Midland (NYSE: ADM ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ADM usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Archer-Daniels Midland. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 12% leaning bullish and 87% bearish. Among these notable options, 5 are puts, totaling $183,890, and 3 are calls, amounting to $88,652. Expected Price Movements Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $57.5 for Archer-Daniels Midl - benzinga
2h ago
link
TSLA US
Market Clubhouse Morning Memo - March 1st, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, And TSLA)
Good Morning Traders! In today's Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market. We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market's pulse to optimize your trading gains. Now, let's dive into the stock analysis: SPDR S&P 500 ETF Trust The SPY (ARCA: SPY) is currently trading around the level of 508.34. For those bullish on SPY, the initial goal is to see the price climb to 508.83. Should the market maintain its strength above this level, the next objective for buyers would be to elevate the price to the support level at 5 - benzinga
2h ago
link
CRM US
Salesforce's top AI ethics leader says she's 'optimistic' on the path to U.S. regulation
'I remain optimistic, because I think if you saw a number of the hearings that happened in the Senate, they were largely bipartisan,' says Paula Goldman. - cnbc
2h ago
link
VCEL US
A Closer Look at 4 Analyst Recommendations For Vericel
In the preceding three months, 4 analysts have released ratings for Vericel (NASDAQ: VCEL ), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 2 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $51.0, a high estimate of $54.00, and a low estimate of $46.00. This upward trend is evident, with the current average reflecting a 13.03% increase from the previous average price target of $45.12. Investigating Analyst Ratings: An Elaborate Study The standing of Vericel am - benzinga
2h ago
link
SQM US
A Glimpse Into The Expert Outlook On Sociedad Quimica Y Minera Through 7 Analysts
In the last three months, 7 analysts have published ratings on Sociedad Quimica Y Minera (NYSE: SQM ), offering a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 4 3 0 0 Last 30D 0 1 1 0 0 1M Ago 0 1 0 0 0 2M Ago 0 1 1 0 0 3M Ago 0 1 1 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.5, a high estimate of $80.00, and a low estimate of $48.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.33%. Analyzing Analyst Ratings: A Detailed Breakdown In examining recent analyst actions, we gain insights into h - benzinga
2h ago
link
CLX US
Beyond The Numbers: 6 Analysts Discuss Clorox Stock
Ratings for Clorox (NYSE: CLX ) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 4 1 1 Last 30D 0 0 0 0 1 1M Ago 0 0 2 0 0 2M Ago 0 0 1 1 0 3M Ago 0 0 1 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $148.67, a high estimate of $170.00, and a low estimate of $118.00. Witnessing a positive shift, the current average has risen by 13.27% from the previous average price target of $131.25. Understanding Analyst Ratings: A Comprehensive Breakdown The standing of Clorox among financial exper - benzinga
2h ago
link
TSLA US
Heres what an AI chatbot thinks of Elon Musks lawsuit against OpenAI and Sam Altman
Who better to turn to than a chatbot for their view of the case? - marketwatch
2h ago
link
GBTC US
Bitcoin, Ethereum Take A Siesta While Dogecoin Surges After February Frenzy; Biden Vs. Trump: Voters Pick One Candidate As Better Bet To Handle Most Election Issues In New Poll - Top Headlines Today While US Was Sleeping
Crypto Bitcoin Analyst Advises ‘Caution’ After Whales Dump King Crypto Worth $4.8B, Says Crucial Indicator Has Flashed ‘Sell Signal’ ‘What’s Happening With Bitcoin Miners?’ Peter Schiff Asks As Crypto Mining Stocks Take A Hit Despite BTC Rally Exclusive: Is Dogecoin Going Legit? Landmark Sale Could Change The Way We Buy Homes Dogecoin Defies Gravity Even As Bitcoin And Ethereum Cool Down, But Technical Indicators Flash Red: Is A Correction Coming? Bitcoin, Ethereum Take A Siesta While Dogecoin Surges After February Frenzy: Analyst Sees Apex Crypto Pulling Back To $46K If Correction Occurs US Markets Investor Optimism Improves Following PCE Report; Nasdaq Surges To Record High US Politics Biden Vs. Trump: Voters Pick One Candidate As Better Bet To Handle Most Election Issues In New Poll – But Can Negative Opinion On This Top Concern Scuttle His Chances? Former Trump Lawyer Says Ex-P - benzinga
2h ago
link
GBTC US
Bitcoin, Ethereum Move Lower; SATS, Mantle Among Top Losers
Bitcoin (CRYPTO: BTC ) moved lower, with the cryptocurrency prices falling below the key $62,000 level on Friday. Ethereum (CRYPTO: ETH ) also recorded losses, but remained above the key $3,400 mark this morning. Axelar (CRYPTO: AXL ) was the top gainer over the prior 24 hours, while SATS (CRYPTO: 1000SATS) turned out to be the biggest loser. At the time of writing, the global ... Full story available on Benzinga.com - benzinga
2h ago
link
PG US
GRND: Gamble on the Gays
Earnings are next Thursday!!!!! Alright WSB. So I (for research purposes) decided to download Grindr and immediately got like 15x as many matches as I did on Tinder. This made me realize that Grindr is probably making HELLA tendies from these insanely active users. It turns out I was right, and GRND is set up for insane growth and $$ in the future. Now I will make this shit short because you all have an attention span shorter than a cocaine crazed monkey. (If you want more information, here's a ton of info I collected about the company https://docs.google.com/document/d/14PLrTHYfY3Hz_udhv2DrDCgGNqeAkdJk7HbvjLLTUh4/edit?usp=sharing ) *WARNING, there are no crayon pictures -- so if you can't read don't click the link Thesis: Americans are lonelier, hornier, and gayer than ever, and who will benefit from that? Grindr! GRND has a large and growing monetizable user base Solid fundamentals with rapidly increasing Revenue and EBITDA Low IV and Beta 94.8% of shares ar - reddit
2h ago
link
FTNT US
Thinking about trading options or stock in Snowflake, Palantir Technologies, Rocket Pharmaceuticals, Fortinet, or Marathon Digital?
NEW YORK, March 1, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNOW, PLTR, RCKT, FTNT, and MARA. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different... - prnewswire:443
2h ago
link
CDXS US
Thinking about buying stock in Societal CDMO, LAVA Therapeutics, Eastman Kodak, Brightspring Health Services, or Codexis?
NEW YORK, March 1, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SCTL, LVTX, KODK, BTSG, and CDXS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.... - prnewswire:443
2h ago
link
NTAP US
Thinking about trading options or stock in Tesla, Leidos, Everbridge, Dell Technologies, or NetApp?
NEW YORK, March 1, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TSLA, LDOS, EVBG, DELL, and NTAP. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different... - prnewswire:443
2h ago
link
LDOS US
Here's How Much You Would Have Made Owning Leidos Holdings Stock In The Last 5 Years
Leidos Holdings (NYSE: LDOS ) has outperformed the market over the past 5 years by 2.62% on an annualized basis producing an average annual return of 15.38%. Currently, Leidos Holdings has a market capitalization of $17.65 billion. Buying $100 In LDOS: If ... Full story available on Benzinga.com - benzinga
2h ago
link
TSLA US
Elon Musk sues OpenAI for abandoning original mission for profit - Reuters
Elon Musk sues OpenAI for abandoning original mission for profit    Reuters Elon Musk sues OpenAI and CEO Sam Altman over contract breach    CNBC Elon Musk's lawsuit is OpenAI's latest headache    Axios NYCB shares plunge, Elon Musk sues OpenAIs Altman    Yahoo Finance Elon Musk sues OpenAI over AI threat    Courthouse News Service - news google
3h ago
link
BAX US
Fulton County Hospital to become part of Baxter Health System
Fulton County Hospital has announced a definitive agreement to join the Baxter Health System, following a unanimous decision by its board. The post Fulton County Hospital to become part of Baxter Health System appeared first on Hospital Management . - hospitalmanagement net
3h ago
link
EVBG US
Why Critical Event Management Company Everbridge Shares Are Rocketing Premarket Friday
Everbridge, Inc.  (NASDAQ: EVBG ) shares are trading higher after it amended and restated the previously announced  merger agreement with Thoma Bravo . As per the terms of the amended and restated deal, Thoma Bravo has increased the price at which it has agreed to acquire all outstanding shares of Everbridge to $35.00 per share in cash, or $6.40 per share higher the original transaction price. The new price, which is higher than that offered by such a third party, values Everbridge at approximately $1.8 billion. The price represents about ... Full story available on Benzinga.com - benzinga
3h ago
link
USO US
Oil prices rise more than 1% as signs indicate tightening market ahead of OPEC+ decision
Oil booked second consecutive monthly gain as front month contracts trade at a premium to later months, which is typically a sign of a tightening oil market. - cnbc
3h ago
link
CPRT US
How Is The Market Feeling About Copart?
Copart's (NYSE: CPRT ) short percent of float has risen 17.82% since its last report. The company recently reported that it has 9.22 million shares sold short , which is 1.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.62 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
3h ago
link
IOVA US
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
Iovance Biotherapeutics's (NYSE: IOVA ) short percent of float has fallen 6.67% since its last report. The company recently reported that it has 42.98 million shares sold short , which is 16.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.73 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
3h ago
link
NCSM US
NCS Multistage Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
HOUSTON, March 01, 2024 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. ('NCS' or the 'Company') (NASDAQ: NCSM ) will host a conference call to discuss its fourth quarter and full year 2023 results on Friday, March 8, 2024 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will issue its fourth quarter and full year 2023 earnings release the evening prior to the conference call. The conference call will be available via a live audio webcast. Participants who wish to ask questions may register for the call Full story available on Benzinga.com - benzinga
3h ago
link
NCSM US
NCS Multistage Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
HOUSTON, March 01, 2024 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NCS or the Company) (NASDAQ:NCSM) will host a conference call to discuss its fourth quarter and full year 2023 results on Friday, March 8, 2024 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will issue its fourth quarter and full year 2023 earnings release the evening prior to the conference call. - globenewswire
3h ago
link
CVNA US
Where Will Carvana Stock Be 10 Years From Now?
This business has huge upside, but only if things go according to plan. - fool
3h ago
link